EZH2 overexpression in myeloma patients shortens survival and in-vitro data supports a potential new targeted treatment strategy
作者
Charlotte Pawlyn,Martin Kaiser,Amy F. Buros,Joshua Epstein,Veronica MacLeod,Fabio Mirabella,Jacqueline H. L. Fok,John R Jones,Ricky D. Edmondson,Bart Barlogie,Bridget E. Walker,Gareth John Morgan,Faith E. Davies